Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER PHARM Plunges 4%; BSE HEALTHCARE Index Up 1.1%
Tue, 6 Aug 12:23

HESTER PHARM Plunges 4%; BSE HEALTHCARE Index Up 1.1%Image source: DNY59/www.istockphoto.com

HESTER PHARM share price has plunged 4% and is presently trading at Rs 2,632.9.

Meanwhile, the BSE HEALTHCARE index is at 40,518.1 (up 1.1%).

Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 1.3%) and SUVEN PHARMACEUTICALS (down 1.3%).

Pfizer (up 4.6%) and Natco Pharma (up 4.4%) are among the top gainers today.

Over the last one year, HESTER PHARM has moved up from Rs 1,741.0 to Rs 2,632.9, registering a gain of Rs 891.9 (up 51.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,485.7 to 40,518.1, registering a gain of 47.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 124.5%), GRANULES INDIA (up 103.7%) and GSK Pharma (up 103.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,322.3 (up 0.7%).

The top gainers among the BSE Sensex today are JSW Steel (up 3.0%) and HCl Tech. (up 2.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,223.8 (up 0.7%). Adani Enterprises and JSW Steel are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,782.8 to 79,322.3, registering a gain of 13,539.5 points (up 20.6%).

HESTER PHARM Financial Update...

HESTER PHARM net profit grew 24.1% YoY to Rs 66 million for the quarter ended June 2024, compared to a profit of Rs 53 million a year ago. Net sales declined 6.4% to Rs 823 million during the period as against Rs 879 million in April-June 2023.

For the year ended March 2024, HESTER PHARM reported 24.5% decrease in net profit to Rs 212 million compared to net profit of Rs 280 million during FY23. Revenue of the company grew 14.5% to Rs 3,045 million during FY24.

The current Price to earnings ratio of HESTER PHARM, based on rolling 12 month earnings, stands at 125.5.


Equitymaster requests your view! Post a comment on "HESTER PHARM Plunges 4%; BSE HEALTHCARE Index Up 1.1%". Click here!